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Conclusions:
The new automated EliA-CTD assay shows superior sensitivity and specificity compared to the conventional labor intensive ANA-IIF. The EliA-CTD can be used as an upfront screening tool for connective tissue diseases. Depending on the clinical details, any EliA-CTD positive results could be reflexly followed by additional testing including ANA-IIF testing to elucidate the titer and pattern. Background: Rheumatoid arthritis (RA) patients benefit from treat-to-target strategies, aiming for remission or low disease activity 1 . Clinical disease activity measures like the Disease Activity Score (DAS28) have questionable reproducibility and lack sensitivity for low disease activity states; MRI and ultrasound (US) are sensitive, but scanning multiple joints is time-consuming. Optical spectral transmission (OST) is stronger than DAS28 associated with inflammation assessed by both US and MRI 2 . OST measures the blood-specific absorption of light transmitted through tissue, which is reduced in presence of joint inflammation, but also influenced by other joint pathology. Objectives: Evaluating the influence of joint pathology on the misclassification of joint inflammation, in the hand and wrist joints of RA patients, determined by OST, as compared to US, the reference standard. Methods: Fifty RA patients with at least one swollen joint, generally with low disease activity were included in this cross-sectional study. Assessments were US, OST, and DAS28, performed according to established guidelines 3 by separate experienced examiners, blinded for other study outcomes. US joint inflammation was defined as a gray-scale score>1 or a power Doppler score>0 (scales 0-3), assessed in MCP, (P)IP, and wrist joints. Using US as reference, diagnostic performance of OST in detecting inflammation at joint level was evaluated using receiver operating characteristic (ROC) analyses; at patient level, DAS28 and OST were correlated to US. Joint pathology potentially influencing misclassification of OST (erosions, osteophytes, tendon (sheet) inflammation, abnormal vasculature, and triangular fibrocartilage complex injuries) were evaluated for significance in a multivariate nominal logistic regression model. Results: OST performed well at joint level, separately for the MCP (ROC-AUC:0.85), PIP (ROC-AUC:0.79) and wrist (ROC-AUC:0.72) joints and for all joints together (ROC-AUC:0.83). On patient level, DAS28 correlated poorly with US (r=0.29), but OST correlation was good (r=0.72). The presence of joint pathologies per misclassification group is shown in table 1. In the regression model, inflammation in MCP and PIP joints had a higher risk of false negative misclassification in the presence of dorsal bone erosions (OR:3.5, 95% CI:1.7-7.3), volar erosions (OR:5.0, 95% CI:1.8-14.1), flexor tenosynovitis (OR:2.5, 95% CI:1.4-4.5), osteophytes (OR:1.9, 95% CI:1.2-2.8), and extensor tendonitis (OR:3.7, 95% CI:1.6-8.5), and a higher risk of false positive misclassification in the presence of osteophytes (OR:2.3, 95% CI:1.6-3.2).
OST is a sensitive and specific technique to assess inflammation in hand and wrist joints of RA patients with low disease activity, nonetheless, joint pathology like erosions, tendonitis, and osteophytes increase the risk of misclassification of inflammation by OST. Background: Joint involvement in SLE is very common, affecting 90% of patients at some stage in the course of their disease (1).Arthritis featuring prominent radiological erosion in SLE is less common; however, in a small subset of patients an erosive pattern similar to RA develops (2). Anti-heterogenous nuclear ribonucleoprotein A2 (anti-hnRNP-A2) occur in about one-third of patients with RA but rarely in other arthritides such as OA, PsA or reactive arthritis. Interestingly, in SLE patients anti-hnRNP-A2 autoantibodies were found to be significantly associated with erosive arthritis (3). Objectives: To investigate joint involvement in SLE and its relationship with autoantibodies to the hnRNP Ab A1 and A2, rheumatoid factor (R.F), Antinuclear antibody (A.N.A) and Anti-double stranded DNA (Anti-DSDNA) and correlation with articular involvement by joint x-ray. Methods: Case series study comparing diagnosis of arthritis by hand and wrist x-ray with anti-hnRNP A1 and A2 in Fourty SLE patients aged 17-60 years old with disease duration 1-17 years complaining of arthralgia or arthritis. A controlled group of 21 clinically normal persons, age and sex matched and blood Background: Recent studies suggest that plaque psoriasis may be a risk factor for major adverse cardiac events. This has important therapeutic implications for cardiovascular (CV) risk stratification and prevention in patients with severe psoriasis. For that reason surrogate markers of subclinical atherosclerosis and CV mortality such as carotid plaques (CP) have been studied by carotid US examination. In most studies of psoriasis done before, the results have shown an increased prevalence of carotid plaques, but it is not always the rule. Objectives: To compare the prevalence of CP between patients with moderatesevere psoriasis and the general population. Methods: A cross-sectional study that included 40 patients with moderatesevere psoriasis (PASI>10, BAS>10%), that fulfilled definitions for initiating treatment with a biological agent and 40 age-, sex-and traditional CV risk factorsmatched healthy control subjects. Patients with history of CV events, diabetes mellitus, and chronic kidney disease or body max index (BMI)>35 were excluded. Carotid ultrasonography was performed by a MyLab 70 scanner (Esaote; Genoa, Italy), then carotid plaque was defined according to the Manheim Consensus Conference criteria. Statistical analysis: Qualitative data were expressed as number and percentages and quantitative data as mean (SD). Student's t test or Mann-Whitney U were used to compare continuous variables, as appropriate. Chi2 test or Fisher test were used for qualitative variables. Results: The main data of the patients are summarized in the Table. It is important to highlight that it is based on a young population (mean age<40 years). The two groups did not present significant differences except for high sensitivity C-reactive protein (hsCRP) As expected given the age of the group, CV risk measured by SCORE was low (0%) with a mean of 0.2 us 0.15. No patient had a high-very high CV risk as measured by SCORE (≥5%). Patients with psoriasis had a long-standing disease (17.05±11.63 years). The presence of carotid plaques was found in a total of 10 patients with plaque psoriasis (25%), 5 of them had bilateral plaques) and one in the control group (2.5%) without bilateral plaques), p<0.003. Background: In Rheumatoid Arthritis (RA) treatment response is assessed using standard clinical disease activity measure. However ultrasound (US) is able to show subclinical synovitis in patients (pts) with RA who are in clinical remission (CR); further studies are still required to delineate the impact of US findings in the management of RA pts in daily clinical practice. Objectives: to investigate the influence of US on the clinicians' treatment choices in pts with RA. Methods: in 2015 an educational event (RECALL Survey) focused on the added value of US in RA pts was held in 22 rheumatology centers in Italy.In every center, the local rheumatologists provided RA pts to be examined by US. Pts signed an informed consent and a brief history of them was collected by the local rheumatologists (previous and current therapy, DAS28, HAQ score). Bilateral US examinations of wrists, metacarpophalangeal (MCP) and metatarsophalangeal (MTP) joints were performed by rheumatologists expert in US, to assess synovitis (joint effusion, synovial proliferation, and power Doppler (PD) signal), and bone erosions, using a Logiq E R7, General Electrics, with a 4.2-13 MHz linear probe. All US findings were scored using a 4 degree semiquantitative scoring system. Results: 465 pts were evaluated. Clinicians, after US evaluations, changed therapy in 23.7% of pts, did not change therapy in 35.5% of pts.In general changes of therapy tended to be made by clinicians when joint effusion or power Doppler signal were present (table 1-2). The presence of erosion did not influence the clinicians' decisions. 
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